MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$41M
Net Income
-$91M
Net Profit Margin
-221.95%
EPS
-$0.72
Unit: Million (M) dollars
Revenue Breakdown
Other Collaboration Revenue
License And Development Services
Revenue Breakdown
Access Rights-Gilead Collaborati...
Gilead Collaboration-License And...
License-Taiho Collaboration-Tran...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
41
17
-32*
26
Research and development (includes 2, 11, 2 and 6 from a related party)
113
122
56*
141
General and administrative (includes , 2, and 2 from a related party)
24
29
26*
27
Impairment of long-lived assets (see note 14, leases)
-
-
0*
0
Total operating expenses
137
151
82*
168
Loss from operations
-96
-134
-114
-142
Interest and other income, net
8
9
10
10
Interest expense
3
3
2
3
Total non-operating income, net
5
6
8
7
Income (loss) before income taxes
-91
-128
-106
-135
Federal statutory income taxes
-
-
19*
-
State taxes, net of federal benefit
-
-
0*
-
Domestic research and development credits
-
-
-4*
-
Equity investment
-
-
3*
-
Stock based compensation
-
-
-1*
-
Other items
-
-
-1*
-
Change in valuation allowance
-
-
-23*
-
Income tax expense
0
0
0
0
Net income (loss)
-91
-128
-106
-135
Basic EPS
-0.72
-1.02
-0.894
-1.27
Diluted EPS
-0.72
-1.02
-0.897
-1.27
Basic Average Shares
126,100,000
125,400,000
118,600,000
106,500,000
Diluted Average Shares
126,100,000
125,400,000
118,200,000
106,500,000
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Net income (loss)
-$91M
Interest and other
income, net
$8M
(-20.00%↓ Y/Y)
Income (loss) before
income taxes
-$91M
Total non-operating
income, net
$5M
(-37.50%↓ Y/Y)
Other Collaboration
Revenue
$25M
License And Development
Services
$16M
Interest expense
$3M
(50.00%↑ Y/Y)
Loss from operations
-$96M
(-1100.00%↓ Y/Y)
Total revenues
$41M
(-74.38%↓ Y/Y)
Total operating
expenses
$137M
(-18.45%↓ Y/Y)
Research and development
(includes 2, 11, 2 and 6 from...
$113M
(-18.71%↓ Y/Y)
General and
administrative (includes , 2, ...
$24M
(-17.24%↓ Y/Y)
Buy us a coffee
Arcus Biosciences, Inc. (RCUS)
Arcus Biosciences, Inc. (RCUS)